Navigation Links
World BioBank(TM) Launch Benefits Advanced Medical Research
Date:4/22/2009

sample requests.

For additional information visit www.WorldBioBank.net

About World BioBank (www.WorldBioBank.net)

Founded by the physician partners of ACORN (Accelerated Community Oncology Research Network), World BioBank embraces forward-thinking technology and a strong commitment to the advancement of bioscience. World BioBank provides industry and academia genetically diverse, high quality, standardized biospecimens with high quality data. Services also include biomarker storage, management and consultation for clinical trials and other scientific study.


'/>"/>
SOURCE World BioBank
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
2. IVF Baby Born From 21-Year-Old Frozen Sperm, Ties World Record
3. Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide
4. Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
5. NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business
6. Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial
7. Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
8. Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics"
9. VisualSonics to Sell Mauna Kea Technologies Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market
10. TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston
11. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014   Lycera Corp ., a ... medicines to treat autoimmune disease and cancer based ... the appointment of Harinder Singh , Ph.D., ... Dr. Singh will lead the board,s efforts to ... ongoing research programs and pipeline of therapies targeting ...
(Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 Genedata, ... drug discovery and life science research, today announced ... will be held in Asia, Europe, and ... global pharmaceutical companies and leading research organizations will ... best practices, case studies, and upcoming challenges in ...
(Date:8/26/2014)... LOVELAND, Colo. , Aug. 26, 2014 /PRNewswire/ ... leading global provider of high-performance crop input products ... today announced that the company has acquired a ... -area agricultural biotechnology company delivering biochemical-based products ... two of Loveland Products, fastest growing plant nutrition ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 2Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 3Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen 4
... The report "Acute Lymphocytic Leukemia Therapeutics ...   - 2020)" analyzes and studies the major market ... & Europe. Browse market data tables ... Forecast & Market Forecast in G8 Countries) (2010   ...
... and Harvard universities have created a new type of ... and have a 3-D structure instead of conventional flat ... build faster, more compact and efficient integrated circuits and ... transistors contain tiny nanowires made not of silicon, like ...
... 6, 2011 Amgen (NASDAQ: AMGN ) ... has modified the requirements of the Nplate® (romiplostim) Risk ... and institutions are no longer required to enroll in ... of EXperts Understanding and Supporting Nplate and Patients) Program, ...
Cached Biology Technology:MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020 2MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020 3New '3-D' transistors promising future chips, lighter laptops 2New '3-D' transistors promising future chips, lighter laptops 3Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy 2Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy 3Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy 4Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy 5Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy 6Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy 7Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy 8
(Date:8/26/2014)... problems such as global warming and poverty the ... burden fall on our failure as consumers to ... study in the Journal of Consumer Research ... global problems from governments to consumers and ultimately ... convince politicians to encourage responsible consumption instead of ...
(Date:8/26/2014)... and the PETA International Science Consortium, LTD (PISC) scientists ... World Congress on Alternatives and Animal Use in the ... use of animals in research, testing and medical training, ... oversight systems. , At the conference, which is being ... PISC will present seven oral and poster presentations, including: ...
(Date:8/25/2014)... month, one of the first U.S. outbreaks of the ... striking some 2,000 people. A university math and biology ... the time to gain insight into how only a ... across the university community., The fall 2009 semester hadn,t ... the university,s Health and Wellness Services clinic11 one day, ...
Breaking Biology News(10 mins):An inconvenient truth: Does responsible consumption benefit corporations more than society? 2WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3
... Aug. 14 SyntheMed, Inc. (OTC,Bulletin Board: SYMD), today ... private placement in which it received $2.8 million in ... stated, "The,proceeds of this financing will help fund the ... quarter of this year." At the closing, the ...
... issue of Nature Methods Shows Application of Bioinformatics ... ... GENEVA, Switzerland, Aug. 21 Researchers at Selexis SA,and ... novel,high-performance Genetic Elements also known as matrix attachment regions,(or ...
... the six billion base pairs from the genome of one ... at the J. Craig Venter Institute (JCVI), along with collaborators ... University of California San Diego (UCSD), have published a genome ... of chromosomes that were inherited from each parent. ...
Cached Biology News:SyntheMed Completes $2.8 Million Equity Financing 2Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines 2First individual genome sequence published 2First individual genome sequence published 3First individual genome sequence published 4
... miRCURY LNA technology enables sensitive and specific ... hybridisation. miRCURY LNA in situ detection probes ... the specific and sensitive detection of miRNAs. ... possible in whole mounts, thin sections, single ...
... This complete kit contains ... separations from a total of ... cells, and includes the StemSep ... necessary reagents and buffers for ...
... to RFC1 Immunogen Recombinant protein corresponding ... C expressed in E. coli. Reactivity / ... Not yet tested in other species. This antibody ... Background Information Replication factor C is a ...
... a K-12 strain ideally suited as an ... transformation efficiency, blue/white screening capability (with appropriate ... in high yields of excellent quality plasmid ... potentially useful as a stringent host due ...
Biology Products: